Your browser doesn't support javascript.
loading
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial.
Peters, Solange; Letovanec, Igor; Mauer, Murielle; Dafni, Urania; Ejedepang, Dunson; Biernat, Wojciech; Bubendorf, Lukas; Warth, Arne; Pokharel, Saraswati; Reinmuth, Niels; Majem Tarruella, Margarita; Casas-Martin, Jose; Tsourti, Zoi; Marti, Nesa; Kammler, Roswitha; Danson, Sarah; O'Brien, Mary; Stahel, Rolf A.
Affiliation
  • Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Letovanec I; Department of Pathology, Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Switzerland, Hôpital du Valais - Institut Central des Hôpitaux (ICH), Sion, Switzerland.
  • Mauer M; Headquarters, European Organisation for Research and Treatment of Cancer (EORTC), 83 Avenue E. Mounier, 1200 Brussels, Belgium.
  • Dafni U; Frontier Science Foundation-Hellas & National and Kapodistrian University of Athens, Athens, Greece.
  • Ejedepang D; Headquarters, European Organisation for Research and Treatment of Cancer (EORTC), 83 Avenue E. Mounier, 1200 Brussels, Belgium.
  • Biernat W; Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland.
  • Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Warth A; Department of Pathology, Universitätsklinikum Heidelberg, Heidelberg, Germany, current address: Institute of Pathology, Cytopathology, and Molecular Pathology MVZ UEGP Giessen / Wetzlar / Limburg, Germany.
  • Pokharel S; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Reinmuth N; Department of Oncology, Asklepios Kliniken GmbH - Asklepios Fachkliniken Muenchen-Gauting, Munich, Germany.
  • Majem Tarruella M; Department of Oncology, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.
  • Casas-Martin J; Headquarters, European Organisation for Research and Treatment of Cancer (EORTC), 83 Avenue E. Mounier, 1200 Brussels, Belgium.
  • Tsourti Z; Frontier Science Foundation-Hellas, Athens, Greece.
  • Marti N; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland.
  • Kammler R; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland.
  • Danson S; Department of Oncology and Metabolism & Sheffield Experimental Cancer Medicine Centre, University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom.
  • O'Brien M; Department of Medical Oncology, Royal Marsden Hospital Sutton, United Kingdom.
  • Stahel RA; President, ETOP IBCSG Partners Foundation, Coordinating Center, Bern, Switzerland. Electronic address: Rolf.Stahel@etop.ibcsg.org.
Lung Cancer ; 175: 141-151, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36535121
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article